Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Bifactor and item response theory analyses of interviewer report scales of cognitive impairment in schizophrenia.

Reise SP, Ventura J, Keefe RS, Baade LE, Gold JM, Green MF, Kern RS, Mesholam-Gately R, Nuechterlein KH, Seidman LJ, Bilder R.

Psychol Assess. 2011 Mar;23(1):245-61. doi: 10.1037/a0021501.

2.

The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ 3rd, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, Seidman LJ, Stover E, Weinberger DR, Young AS, Zalcman S, Marder SR.

Am J Psychiatry. 2008 Feb;165(2):203-13. doi: 10.1176/appi.ajp.2007.07010042. Epub 2008 Jan 2.

PMID:
18172019
3.

Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study.

Green MF, Nuechterlein KH, Kern RS, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Seidman LJ, Stover E, Marder SR.

Am J Psychiatry. 2008 Feb;165(2):221-8. doi: 10.1176/appi.ajp.2007.07010089. Epub 2008 Jan 2.

PMID:
18172017
4.

Clinical global impression of cognition in schizophrenia (CGI-CogS): reliability and validity of a co-primary measure of cognition.

Ventura J, Cienfuegos A, Boxer O, Bilder R.

Schizophr Res. 2008 Nov;106(1):59-69. Epub 2007 Sep 27.

PMID:
17900866
5.

Cognition, drug treatment, and functional outcome in schizophrenia: a tale of two transitions.

Green MF.

Am J Psychiatry. 2007 Jul;164(7):992-4. No abstract available.

PMID:
17606645
6.

Cognitive impairment in schizophrenia: clinical ratings are not a suitable alternative to neuropsychological testing.

Hofer A, Niedermayer B, Kemmler G, Rettenbacher MA, Trebo E, Widschwendter CG, Fleischhacker WW.

Schizophr Res. 2007 May;92(1-3):126-31. Epub 2007 Mar 12.

PMID:
17350807
7.

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.

U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research.; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research.; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health..

Health Qual Life Outcomes. 2006 Oct 11;4:79.

8.
9.

Identification of separable cognitive factors in schizophrenia.

Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK.

Schizophr Res. 2004 Dec 15;72(1):29-39. Review.

PMID:
15531405
10.

Cognitive deficits as treatment targets in schizophrenia.

Gold JM.

Schizophr Res. 2004 Dec 15;72(1):21-8.

PMID:
15531404
11.

Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria.

Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, Keefe RS, Kern RS, Kraemer H, Stover E, Weinberger DR, Zalcman S, Marder SR.

Biol Psychiatry. 2004 Sep 1;56(5):301-7. Review.

PMID:
15336511
13.

Self-assessed cognitive dysfunction and objective performance in outpatients with schizophrenia participating in a rehabilitation program.

Prouteau A, Verdoux H, Briand C, Lesage A, Lalonde P, Nicole L, Reinharz D, Stip E.

Schizophr Res. 2004 Jul 1;69(1):85-91.

PMID:
15145474
14.

Exploring cognitive complaints in schizophrenia: the subjective scale to investigate cognition in schizophrenia.

Stip E, Caron J, Renaud S, Pampoulova T, Lecomte Y.

Compr Psychiatry. 2003 Jul-Aug;44(4):331-40.

PMID:
12923712
15.

Another view of therapy for cognition in schizophrenia.

Carpenter WT, Gold JM.

Biol Psychiatry. 2002 Jun 15;51(12):969-71. No abstract available.

PMID:
12062880
16.

UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults.

Patterson TL, Goldman S, McKibbin CL, Hughs T, Jeste DV.

Schizophr Bull. 2001;27(2):235-45.

PMID:
11354591
17.

Causal mechanisms of subjective cognitive dysfunction in schizophrenic and depressed patients.

van den Bosch RJ, Rombouts RP.

J Nerv Ment Dis. 1998 Jun;186(6):364-8.

PMID:
9653421
18.

Supplemental Content

Support Center